Keywords: Sanofi Pasteur, Sanofi-Aventis, Vaccine, H1N1, Pediatric, Syntiron, MRSA, C.Difficile

Sanofi Pasteur expands C. difficile study into USA; gets rights to MRSA agent; parent withdraws few batches of pediatric H1N1 vaccine

Article | 16 December 2009

Print This

Sanofi Pasteur, the vaccines division of French drug major Sanofi-Aventis, is expanding its Phase II clinical study of a vaccine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in